Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Jun 22;6(6):CD013285.
doi: 10.1002/14651858.CD013285.pub2.

Exercise versus airway clearance techniques for people with cystic fibrosis

Katie D Heinz  1 , Adam Walsh  2 , Kevin W Southern  3 , Zoe Johnstone  4 , Kate H Regan  5
Affiliations
Meta-Analysis

Exercise versus airway clearance techniques for people with cystic fibrosis

Katie D Heinz et al. Cochrane Database Syst Rev. .

Abstract

Background: There are many accepted airway clearance techniques (ACTs) for managing the respiratory health of people with cystic fibrosis (CF); none of which demonstrate superiority. Other Cochrane Reviews have reported short-term effects related to mucus transport, but no evidence supporting long-term benefits. Exercise is an alternative ACT thought to produce shearing forces within the lung parenchyma, which enhances mucociliary clearance and the removal of viscous secretions. Recent evidence suggests that some people with CF are using exercise as a substitute for traditional ACTs, yet there is no agreed recommendation for this. Additionally, one of the top 10 research questions identified by people with CF is whether exercise can replace other ACTs. Systematically reviewing the evidence for exercise as a safe and effective ACT will help people with CF decide whether to incorporate this strategy into their treatment plans and potentially reduce their treatment burden. The timing of this review is especially pertinent given the shifting landscape of CF management with the advent of highly-effective small molecule therapies, which are changing the way people with CF are cared for.

Objectives: To compare the effect of exercise to other ACTs for improving respiratory function and other clinical outcomes in people with CF and to assess the potential adverse effects associated with this ACT.

Search methods: On 28 February 2022, we searched the Cochrane Cystic Fibrosis Trials Register, compiled from electronic database searches and handsearching of journals and conference abstract books. We also searched the reference lists of relevant articles and reviews. We searched online clinical trial registries on 15 February 2022. We emailed authors of studies awaiting classification or potentially eligible abstracts for additional information on 1 February 2021.

Selection criteria: We selected randomised controlled studies (RCTs) and quasi-RCTs comparing exercise to another ACT in people with CF for at least two treatment sessions.

Data collection and analysis: Two review authors independently extracted data and assessed risk of bias for the included studies. They assessed the certainty of the evidence using GRADE. Review authors contacted investigators for further relevant information regarding their publications.

Main results: We included four RCTs. The 86 participants had a wide range of disease severity (forced expiratory volume in one second (FEV1) ranged from 54% to 95%) and were 7 to 41 years old. Two RCTs were cross-over and two were parallel in design. Participants in one RCT were hospitalised with an acute respiratory exacerbation, whilst the participants in three RCTs were clinically stable. All four RCTs compared exercise either alone or in combination with another ACT, but these were too diverse to allow us to combine results. The certainty of the evidence was very low; we downgraded it due to low participant numbers and high or unclear risks of bias across all domains. Exercise versus active cycle of breathing technique (ACBT) One cross-over trial (18 participants) compared exercise alone to ACBT. There was no change from baseline in our primary outcome FEV1, although it increased in the exercise group before returning to baseline after 30 minutes; we are unsure if exercise affected FEV1 as the evidence is very low-certainty. Similar results were seen for other measures of lung function. No adverse events occurred during the exercise sessions (very low-certainty evidence). We are unsure if ACBT was perceived to be more effective or was the preferred ACT (very low-certainty evidence). 24-hour sputum volume was less in the exercise group than with ACBT (secondary outcome). Exercise capacity, quality of life, adherence, hospitalisations and need for additional antibiotics were not reported. Exercise plus postural drainage and percussion (PD&P) versus PD&P only Two trials (55 participants) compared exercise and PD&P to PD&P alone. At two weeks, one trial narratively reported a greater increase in FEV1 % predicted with PD&P alone. At six months, the other trial reported a greater increase with exercise combined with PD&P, but did not provide data for the PD&P group. We are uncertain whether exercise with PD&P improves FEV1 as the certainty of evidence is very low. Other measures of lung function did not show clear evidence of effect. One trial reported no difference in exercise capacity (maximal work rate) after two weeks. No adverse events were reported (1 trial, 17 participants; very low-certainty evidence). Adherence was high, with all PD&P sessions and 96% of exercise sessions completed (1 trial, 17 participants; very low-certainty evidence). There was no difference between groups in 24-hour sputum volume or in the mean duration of hospitalisation, although the six-month trial reported fewer hospitalisations due to exacerbations in the exercise and PD&P group. Quality of life, ACT preference and need for antibiotics were not reported. Exercise versus underwater positive expiratory pressure (uPEP) One trial (13 participants) compared exercise to uPEP (also known as bubble PEP). No adverse events were recorded in either group (very low-certainty evidence). Trial investigators reported that participants perceived exercise as more fatiguing but also more enjoyable than bubble PEP (very low-certainty evidence). There were no differences found in the total weight of sputum collected during treatment sessions. The trial did not report the primary outcomes (FEV1, quality of life, exercise capacity) or the secondary outcomes (other measures of lung function, adherence, need for antibiotics or hospitalisations).

Authors' conclusions: As one of the top 10 research questions identified by clinicians and people with CF, it is important to systematically review the literature regarding whether or not exercise is an acceptable and effective ACT, and whether it can replace traditional methods. We identified an insufficient number of trials to conclude whether or not exercise is a suitable alternative ACT, and the diverse design of included trials did not allow for meta-analysis of results. The evidence is very low-certainty, so we are uncertain about the effectiveness of exercise as an ACT. Longer studies examining outcomes that are important to people with CF are required to answer this question.

PubMed Disclaimer

Conflict of interest statement

KH: none known.

AW: none known.

KWS: none known.

ZJ: none known.

KHR: none known.

Figures

1
1
PRISMA flow diagram of study selection process
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study
1.1
1.1. Analysis
Comparison 1: Exercise plus PD&P versus PD&P alone, Outcome 1: Hospitalisations
1.2
1.2. Analysis
Comparison 1: Exercise plus PD&P versus PD&P alone, Outcome 2: Duration of hospitalisations
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD013285

References

References to studies included in this review

Almajan‐Guta 2011 {published data only}
    1. Almajan-Guta B, Avram C, Almajan-Guta V, Rusu A, Ciuca I, Cluci O, et al. High motivation for playing sports in cystic fibrosis - what we play is life. Journal of Cystic Fibrosis 2011;10(Suppl 1):S64. [ABSTRACT: 254] [CFGD REGISTER: PE189]
Balestri 2004 {published data only}
    1. Balestri E, Ambroni M, Dall' Ara S, Miano A. Efficacy of physical exercise for mucus clearance in patients with cystic fibrosis (CF). Pediatric Pulmonology 2004;38(Suppl 27):316. [CFGD REGISTER: PE150]
Bilton 1992 {published data only}
    1. Bilton D, Dodd M, Webb AK. The benefits of exercise combined with physiotherapy in cystic fibrosis. Pediatric Pulmonology 1990;9(Suppl 5):253-4. [ABSTRACT: 238] [CFGD REGISTER: PE41a]
    1. Bilton D, Dodd ME, Abbot JV, Webb AK. The benefits of exercise combined with physiotherapy in the treatment of adults with cystic fibrosis. Respiratory Medicine 1992;86(6):507-11. [CFGD REGISTER: PE41b] [DOI: 10.1016/S0954-6111(96)80012-6] - DOI - PubMed
Cerny 1989 {published data only}
    1. Cerny FJ. Relative effects of bronchial drainage and exercise for in-hospital care of patients with cystic fibrosis. Physical Therapy 1989;69(8):633-9. [CFGD REGISTER: PE13] [DOI: 10.1093/ptj/69.8.633] - DOI - PubMed

References to studies excluded from this review

Alexander 2019 {published data only}
    1. Alexander E, Wilson C, Kapur N, Brookes D. Is telehealth as effective as face to face therapy for delivery of whole body vibration training (WBVT) as an adjunct to physiotherapy in children and young people with cystic fibrosis (CF)? Respirology 2019;24:135. [CFGD REGISTER: MH178]
Aquino 2006 {published data only}
    1. Aquino A, Balestri E, Dall 'Ara S, Lami I, Gobbi F, Ambroni M, et al. Efficacy of physical exercise playing a video game for mucus clearance in patients with cystic fibrosis. Journal of Cystic Fibrosis 2006;5(Suppl 1):S83. [CFGD REGISTER: PE163]
Baldwin 1994 {published data only}
    1. Baldwin DR, Hill AL, Peckham DG, Knox AJ. Effect of addition of exercise to chest physiotherapy on sputum expectoration and lung function in adults with cystic fibrosis. Respiratory Medicine 1994;88(1):49-53. [CFGD REGISTER: PE19] [DOI: 10.1016/0954-6111(94)90174-0] - DOI - PubMed
Dwyer 2019 {published data only}ACTRN12608000287336
    1. ACTRN12608000287336. Does exercise enhance mucociliary clearance in adults with cystic fibrosis? trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12608000287336 (date registered 4 June 2008). [CFGD REGISTER: PE274b]
    1. Dwyer TJ, Daviskas E, Zainuldin R, Verschuer J, Eberl S, Bye P, et al. Effects of exercise and airway clearance (positive expiratory pressure) on mucus clearance in cystic fibrosis: a randomised crossover trial. European Respiratory Journal 2019;53(4):1801793. [CFGD REGISTER: PE274a] [DOI: 10.1183/13993003.01793-2018] - DOI - PubMed
Falk 1988 {published data only}
    1. Falk M, Kelstrup M, Andersen JB, Pedersen SS, Rossing I, Dirksen H. PEP treatment or physical exercise. Effects on secretions expectorated and indices of central and peripheral airway function. A controlled study. In: 10th International Cystic Fibrosis Congress; 1988 March 5-10; Sydney. 1988:35. [CFGD REGISTER: PE36]
Kaak 2011 {published data only}
    1. Kaak I, Helbig I, Ankermann T. Didgeridoo playing as an adjunctive therapy to conventional physiotherapy for patients with cystic fibrosis. Zeitschrift fur Physiotherapeuten 2011;63(2):6-14. [CFGD REGISTER: PE292]
Lannefors 1992 {published data only}
    1. Lannefors L, Wollmer P. Mucus clearance in cystic fibrosis (CF) - a comparison between postural drainage, PEP-mask and physical exercise. In: 11th International Cystic Fibrosis Congress; 1992; Dublin, Ireland. 1992:AHP31. [CFGD REGISTER: PE46a] - PubMed
    1. Lannefors L, Wollmer P. Mucus clearance with three chest physiotherapy regimes in cystic fibrosis: a comparison between postural drainage, PEP and physical exercise. European Respiratory Journal 1992;5(6):748-53. [CFGD REGISTER: PE46b] - PubMed
Montero‐Ruiz 2020 {published data only}
    1. Frias JP, Montero-Ruiz A, Galvez LA F, Perez-Ruiz E, Huelamo MP, Martin-Montañez E. A music therapy intervention as an adjunct to chest physiotherapy in children with cystic fibrosis. European Respiratory Journal 2018;52(Suppl 62):PA4626. [CFGD REGISTER: PE293b]
    1. Montero-Ruiz A, Fuentes LA, Perez Ruiz E, Garcia-Agua Soler N, Rius-Diaz F, Caro Aguilera P, et al. Effects of music therapy as an adjunct to chest physiotherapy in children with cystic fibrosis: a randomized controlled trial. PloS one 2020;15(10):e0241334. [CFGD REGISTER: PE293a] - PMC - PubMed
NCT00609050 {published data only}
    1. NCT00609050. Exercise training study for patients with cystic fibrosis [Self-regulated exercise in CF: a randomized trial]. clinicaltrials.gov/ct2/show/NCT00609050 (first posted 6 February 2008).
NCT00792194 {published data only}
    1. NCT00792194. Improvement of aerobic capacity in cystic fibrosis patients with a one-year home training period. clinicaltrials.gov/ct2/show/NCT00792194 (first posted 17 November 2008).
NCT03295201 {published data only}
    1. NCT03295201. Clinical effects of exercise program added to pulmonary rehabilitation in patients with cystic fibrosis. clinicaltrials.gov/ct2/show/NCT03295201 (first posted 27 September 2017).
Radtke 2018 {published data only}
    1. NCT02750722. Exercise and oscillatory positive expiratory pressure therapy in cystic fibrosis [Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusion capacity in cystic fibrosis: a randomized crossover trial]. clinicaltrials.gov/ct2/show/NCT02750722 (first posted 25 April 2016). [CFGD REGISTER: PE255d]
    1. Radtke T, Boeni L, Bohnacker P, Maggi-Bebba M, Fischer P, Kriemler S, et al. Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial. European Respiratory Journal 2018;52(Suppl 62):PA3418. [CFGD REGISTER: PE255e] - PMC - PubMed
    1. Radtke T, Boeni L, Bohnacker P, Maggi-Bebba M, Fischer P, Kriemler S, et al. Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial. Journal of Cystic Fibrosis 2018;17(Suppl 3):S15. [CFGD REGISTER: PE255b] - PMC - PubMed
    1. Radtke T, Boni L, Bohnacker P, Fischer P, Benden C, Dressel H. The many ways sputum flows - dealing with high within-subject variability in cystic fibrosis sputum rheology. Respiratory Physiology & Neurobiology 2018;254:36-9. [CFGD REGISTER: PE255c] - PubMed
    1. Radtke T, Boni L, Bohnacker P, Maggi-Beba M, Fischer P, Kriemler S, et al. Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial. BMC Pulmonary Medicine 2018;18(1):99. [CFGD REGISTER: PE255a] - PMC - PubMed
Reix 2012 {published data only}
    1. NCT01509235. Self drainage in pediatric cystic fibrosis patients [Exercise coupled to self drainage in pediatric cystic fibrosis patients: an open label cross over randomised clinical trial]. clinicaltrials.gov/show/NCT01509235 (first posted 12 January 2012). [CFGD REGISTER: PE183c]
    1. Reix P, Aubert F, Kassai B, Bige V, Bellon G. Better satisfaction of cystic fibrosis paediatric patients with autogenic drainage associated to exercise compared to conventional chest physiotherapy. Journal of Cystic Fibrosis 2009;8(Suppl 2):S73. [ABSTRACT: 293] [CFGD REGISTER: PE183a] [DOI: 10.1016/s1569-1993(09)60288-5] - DOI
    1. Reix P, Aubert F, Werck-Gallois MC, Toutain A, Mazzocchi C, Moreux N, et al. Exercise with incorporated expiratory manoeuvres was as effective as breathing techniques for airway clearance in children with cystic fibrosis: a randomised crossover trial. Journal of Physiotherapy 2012;58(4):241-7. [CFGD REGISTER: PE183b] - PubMed
Rodriguez 2017 {published data only}
    1. Rodriguez M, Cortina S, Carro M, Ruiz-de-Valbuena M, Cosmes J. A pulmonary rehabilitation program to increase adherence to airway clearance techniques for children and adults with cystic fibrosis. Journal of Cystic Fibrosis 2017;16(Suppl 1):S58. [ABSTRACT: IPD.01]
Salh 1989 {published data only}
    1. Salh W, Bilton D, Dodd M, Webb AK. Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis. Thorax 1989;44(12):1006-8. [CFGD REGISTER: PE63] [DOI: 10.1136/thx.44.12.1006] - DOI - PMC - PubMed
Santana‐Sosa 2014 {published data only}
    1. NCT01706445. Combined inspiratory muscle and 'whole muscle' training in children with cystic fibrosis. clinicaltrials.gov/show/NCT01706445 (date first posted 15 October 2012). [CFGD REGISTER: PE201b]
    1. Santana-Sosa E, Gonzalez-Saiz L, Groeneveld IF, Villa-Asensi JR, Barrio Gomez de Aguero MI, Fleck SJ, et al. Benefits of combining inspiratory muscle with 'whole muscle' training in children with cystic fibrosis: a randomised controlled trial. British Journal of Sports Medicine 2014;48(20):1513-7. [CFGD REGISTER: PI201a] - PubMed
Zeren 2019 {published data only}
    1. NCT03375684. Effects of inspiratory muscle training on postural stability, balance, pulmonary function and functional capacity in children with cystic fibrosis. clinicaltrials.gov/show/NCT03375684 (first posted 18 December 2017). [CFGD REGISTER: PE275c]
    1. Zeren M, Cakir E, Gurses HN. Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Respiratory Medicine 2019;148:24-30. [CFGD REGISTER: PE275a] - PubMed
    1. Zeren M, Cakir E, Gurses HN. Effects of inspiratory muscle training on postural stability, pulmonary function and functional capacity in children with cystic fibrosis: a randomised controlled trial. Turkish Thoracic Journal 2019;20:S106. [CFGD REGISTER: PE275b] - PubMed

References to studies awaiting assessment

Ward 2018 {published data only}
    1. Ward N, Stiller K, Rowe H, Morrow S, Morton J, Greville H, et al. Airway clearance by exercising in mild cystic fibrosis: clinical outcomes. Respirology 2018;23(Suppl 1):140. [CFGD REGISTER: PE257a] - PubMed
    1. Ward N, Stiller K, Rowe H, Morrow S, Morton J, Greville H, et al. Airway clearance by exercising in mild cystic fibrosis (ACE-CF): a feasibility study. Respiratory Medicine 2018;142:23-8. [CFGD REGISTER: PE257b] [DOI: 10.1016/j.rmed.2018.07.008] - DOI - PubMed

References to ongoing studies

NCT03273959 {published and unpublished data}
    1. NCT03273959. Program of exercises during the hospitalization of children and adolescents with cystic fibrosis [Effects of an exercise program during the hospitalization of children and adolescents with cystic fibrosis: randomized clinical test]. clinicaltrials.gov/ct2/show/NCT03273959 (first posted 6 September 2016).

Additional references

Bailey 2021
    1. Bailey J, Rozga M, McDonald CM, Bowser EK, Farnham K, Mangus M. Effect of CFTR modulators on anthropometric parameters in individuals with cystic fibrosis: an Evidence Analysis Center Systematic Review . Journal of the Academy of Nutrition and Dietetics 2021;121(7):1364-78. - PubMed
Boas 1997
    1. Boas SR. Exercise recommendations for individuals with cystic fibrosis. Journal of Sports Medicine 1997;24(1):17-37. - PubMed
Burnham 2021
    1. Burnham P, Stanford G, Stewart R. Autogenic drainage for airway clearance in cystic fibrosis. Cochrane Database of Systematic Reviews 2021, Issue 12. Art. No: CD009595. [DOI: 10.1002/14651858.CD009595.pub3] - DOI - PMC - PubMed
Cerny 2013
    1. Cerny F. Exercise and cystic fibrosis (CF) 2.0. Pediatric Exercise Science 2013;25(4):616-23. - PubMed
Cholewa 2012
    1. Cholewa JM, Paolone VJ. Influence of exercise on airway epithelia in cystic fibrosis: a review. Medicine and Science in Sports and Exercise 2012;44(7):1219-26. - PubMed
Covidence [Computer program]
    1. Covidence. Version accessed 10 February 2019. Melbourne, Australia: Veritas Health Innovation. Available at www.covidence.org.
Cox 2018
    1. Cox NS, Alison JA, Button BM, Wilson JW, Morton JM, Holland AE. Accumulating physical activity in at least 10-minute bouts predicts better lung function after 3-years in adults with cystic fibrosis. European Respiratory Journal 2018;4(2):00095-2017. [DOI: 10.1183/23120541.00095-2017] - DOI - PMC - PubMed
Dasgupta 1998
    1. Dasgupta B, Brown NE, King M. Effects of sputum oscillations and rhDNase in vitro: a combined approach to treat cystic fibrosis lung disease. Pediatric Pulmonology 1998;26(4):250-5. - PubMed
Dassios 2013
    1. Dassios T, Katelari A, Doudounakis S, Dimitriou G. Aerobic exercise and respiratory muscle strength in patients with cystic fibrosis. Respiratory Medicine 2013;107(5):684-90. - PubMed
Deeks 2021
    1. Deeks JJ, Higgins JP, Altman DG on behalf of the Cochrane Statistical Methods Group, editor(s). Chapter 10: Analysing data and undertaking meta-analysis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). The Cochrane Collaboration, 2021. Available from training.cochrane.org/handbook.
Dwyer 2011
    1. Dwyer TJ, Alison JA, McKeough ZJ, Daviskas E, Bye PT. Effects of exercise on respiratory flow and sputum properties in patients with cystic fibrosis. Chest 2011;139(4):870-7. - PubMed
Dwyer 2021
    1. Dwyer T. Huff and puff of exercise for airway clearance in cystic fibrosis: how clear is the evidence? Thorax 2021;76:746-7. - PubMed
Ekkekakis 2011
    1. Ekkekakis P, Parfitt G, Petruzzello SJ. The pleasure and displeasure people feel when they exercise at different intensities: decennial update and progress towards a tripartite rationale for exercise intensity prescription. Journal of Sports Medicine 2011;41(8):641-71. - PubMed
Elbourne 2002
    1. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9. - PubMed
Farrell 2008
    1. Farrell PM. The prevalence of cystic fibrosis in the European Union. Journal of Cystic Fibrosis 2008;7(5):450-3. - PubMed
Farrell 2018
    1. Farrell P, Férec C, Macek M, Frischer T, Renner S, Riss K, et al. Estimating the age of p.(Phe508del) with family studies of geographically distinct European populations and the early spread of cystic fibrosis. European Journal of Human Genetics 2018;26(12):1832-9. [DOI: 10.1038/s41431-018-0234-z] - DOI - PMC - PubMed
Flume 2009
    1. Flume PA, Robinson KA, O ´ Sullivan BP, Finder JD, Vender RL, Willey-Courand DB, et al. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respiratory Care 2009;54(4):522-37. - PubMed
Gee 2000
    1. Gee L, Abbott J, Conway S, Etherington C, Webb A. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000;55(11):946-54. - PMC - PubMed
Greenland 1985
    1. Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985;41(1):55-68. - PubMed
Greut 2021
    1. Gruet M, Saynor ZL, Urquhart DS, Radtke T. Rethinking physical exercise training in the modern era of cystic fibrosis: a step towards optimising short-term efficacy and long-term engagement. Journal of Cystic Fibrosis 2021 Sep 04 [Epub ahead of print]. [DOI: 10.1016/j.jcf.2021.08.004] - DOI - PubMed
Groth 1985
    1. Groth S, Stafanger G, Dirksen H, Andersen JB, Falk M, Kelstrup M. Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bulletin Européen de Physiopathologie Respiratoire 1995;21(4):339-43. - PubMed
Guyatt 1987
    1. Guyatt G, Berman L, Townsend M, Pugsley S, Chambers L. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42(10):773-8. - PMC - PubMed
Hansen 1994
    1. Hansen LG, Warwick WJ, Hansen KL. Mucus transport mechanisms in relation to the effect of high frequency chest compression (HFCC) on mucus clearance. Pediatric Pulmonology 1994;17(2):113-8. - PubMed
Hebestreit 2001
    1. Hebestreit A, Kersting U, Basler B, Jeschke R, Hebestreit H. Exercise inhibits epithelial sodium channels in patients with cystic fibrosis. American Journal of Respiratory Critical Care Medicine 2001;164(3):443-6. - PubMed
Hebestreit 2015
    1. Hebestreit H, Arets HG, Aurora P, Boas S, Cerny F, Hulzebos EH, et al. Statement on exercise testing in cystic fibrosis. Respiration 2015;90(4):332-51. - PubMed
Hebestreit 2018
    1. Hebestreit H, Lands LC, Alarie N, Schaeff J, Karila C, Orenstein DM, et al. Effects of a partially supervised conditioning programme in cystic fibrosis: an international multi-centre randomised controlled trial (ACTIVATE-CF): study protocol. BMC Pulmonary Medicine 2018;18(1):31. - PMC - PubMed
Hebestreit 2019
    1. Hebestreit H, Hulzebos E, Schneiderman J, Karila C, Boas SR, Kriemler S, et al. Cardiopulmonary exercise testing provides additional prognostic information in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 2019;199(8):987-95. [DOI: 10.1164/rccm.201806-1110OC] - DOI - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. - PMC - PubMed
Higgins 2017
    1. Higgins JP, Altman DG, Sterne JA, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2/.
Hind 2008
    1. Hind K, Truscott JG, Conway SP. Exercise during childhood and adolescence: a prophylaxis against cystic fibrosis-related low bone mineral density? Exercise for bone health in children with cystic fibrosis. Journal of Cystic Fibrosis 2008;7(4):270-6. - PubMed
Hurley 2021
    1. Hurley N, Moyna NM, Kehoe B, McCaffrey N, Redmond K, Hardcastle SJ. Factors influencing physical activity in adults with cystic fibrosis. BMC Pulmonary Medicine 2021;21:113. - PMC - PubMed
Irons 2019
    1. Irons JY, Petocz P, Kenny DT, Chang AB. Singing as an adjunct therapy for children and adults with cystic fibrosis. Cochrane Database of Systematic Reviews 2019, Issue 7. Art. No: CD008036. [DOI: 10.1002/14651858.CD008036.pub5] - DOI - PMC - PubMed
Jones 1991
    1. Jones PW, Quirk FH, Baveystock CM. The St. George's Respiratory Questionnaire. Respiratory Medicine 1991;85(Suppl 2):25-31. [DOI: 10.1016/S0954-6111(06)80166-6] - DOI - PubMed
Keogh 2018
    1. Keogh RH, Szczesniak R, Taylor-Robinson D, Bilton D. Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: a longitudinal study using UK patient registry data. Journal of Cystic Fibrosis 2018;17(2):218–27. - PMC - PubMed
Klijn 2004
    1. Klijn PH, Oudshoorn A, Ent CK, Net J, Kimpen JL, Helders PJ. Effects of anaerobic training in children with cystic fibrosis: a randomized controlled study. Chest 2004;125(4):1299-305. - PubMed
Koch 1993
    1. Koch C, Høiby N. Pathogenesis of cystic fibrosis. Lancet 1993;341(8852):1065-9. - PubMed
LeBlanc 2014
    1. LeBlanc CM, Lands LC. Can I play? Pediatric Annals 2014;43(12):316-24. - PubMed
Lewis 2016
    1. Lewis BA, Williams DM, Frayeh A, Marcus BH. Self-efficacy versus perceived enjoyment as predictors of physical activity behaviour. Psychology & Health 2016;31:456-69. - PMC - PubMed
Litvin 2019
    1. Litvin M, Yoon JC, Leey Casella J, Blackman SM, Brennan AL. Energy balance and obesity in individuals with cystic fibrosis. Journal of Cystic Fibrosis 2019;18(2):38-47. - PubMed
Main 2005
    1. Main E, Prasad A, Schans CP. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No: CD002011. [DOI: 10.1002/14651858.CD002011.pub2] - DOI - PMC - PubMed
Mantel 1959
    1. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959;22(4):719-48. - PubMed
McIlwaine 2006
    1. McIlwaine M. Physiotherapy and airway clearance techniques and devices. Paediatric Respiratory Reviews 2006;7(Suppl 1):S220-2. - PubMed
McIlwaine 2019
    1. McIlwaine M, Button B, Nevitt SJ. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2019, Issue 11. Art. No: CD003147. [DOI: 10.1002/14651858.CD003147.pub5] - DOI - PMC - PubMed
Mckoy 2016
    1. Mckoy NA, Wilson LM, Saldanha IJ, Odelola OA, Robinson KA. Active cycle of breathing technique for cystic fibrosis. Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No: CD007862. [DOI: 10.1002/14651858.CD007862.pub3] - DOI - PMC - PubMed
Middleton 2019
    1. Middleton PG, Mall MA, Dřevínek P, Lands LC, McKone EF, Polineni D, et al. Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a single Phe508del allele. New England Journal of Medicine 2019;381:1809-19. [DOI: 10.1056/NEJMoa1908639] - DOI - PMC - PubMed
Morrison 2020
    1. Morrison L, Milroy S. Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2020, Issue 4. Art. No: CD006842. [DOI: 10.1002/14651858.CD006842.pub5] - DOI - PMC - PubMed
Nixon 1992
    1. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. New England Journal of Medicine 1992;327(25):1785-8. - PubMed
Perrem 2018
    1. Perrem L, Rayment JH, Ratjen F. The lung clearance index as a monitoring tool in cystic fibrosis: ready for the clinic? Current Opinion in Pulmonary Medicine 2018;24(6):579-85. [DOI: 10.1097/MCP.0000000000000515] - DOI - PubMed
Pescatello 2014
    1. Pescatello LS, Arena R, Riebe D, Thompson PD. ACSM’s guidelines for exercise testing and prescription 9th edition. Journal of Canadian Chiropractic Association 2014;58(3):328.
Pianosi 2005
    1. Pianosi P, Leblanc J, Almudevar A. Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax 2005;60(1):50-4. [DOI: 10.1136/thx.2003.008102] - DOI - PMC - PubMed
Pocock 1987
    1. Pocock S, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. A survey of three medical journals. New England Journal of Medicine 1987;317(7):426-32. - PubMed
Prasad 1993
    1. Prasad SA. Current concepts in physiotherapy. Journal of the Royal Society of Medicine 1993;86(20):23-9. - PMC - PubMed
Quittner 2009
    1. Quittner AL, Modi AC, Wainwright C, Otto K, Kirihara J, Montgomery AB. Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest 2009;135(6):1610-8. - PMC - PubMed
Radtke 2017
    1. Radtke T, Nevitt SJ, Hebestreit H, Kriemler S. Physical exercise training for cystic fibrosis. Cochrane Database of Systematic Reviews 2017, Issue 11. Art. No: CD002768. [DOI: 10.1002/14651858.CD002768.pub4] - DOI - PMC - PubMed
Rand 2012
    1. Rand S, Prasad SA. Exercise as part of a cystic fibrosis therapeutic routine. Expert Review of Respiratory Medicine 2012;6(3):341-52. - PubMed
RevMan 2020 [Computer program]
    1. Review Manager (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.
Rosenfeld 2001
    1. Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery B, et al. Defining a pulmonary exacerbation in cystic fibrosis. Journal of Pediatrics 2001;139(3):359-65. - PubMed
Rowbotham 2018
    1. Rowbotham NJ, Smith S, Leighton PA, Rayner O, Gathercole K, Elliott ZC, et al. The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers. Thorax 2018;73(4):388-90. - PMC - PubMed
Rowbotham 2020
    1. Rowbotham NJ, Smith SJ, Davies G, Daniels T, Elliott ZC, Gathercole K, et al. Can exercise replace airway clearance techniques in cystic fibrosis? A survey of patients and healthcare professionals.. Journal of Cystic Fibrosis 2020;19(4):19-24. - PubMed
Sawicki 2009
    1. Sawicki GS, Sellers DE, Robinson WM. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. Journal of Cystic Fibrosis 2009;8(2):91-6. - PMC - PubMed
Sawyer 2004
    1. Sawyer MG, Reynolds KE, Couper JJ, French DJ, Kennedy D, Martin J, et al. Health-related quality of life of children and adolescents with chronic illness – a two year prospective study. Quality of Life Research 2004;13(7):1309-19. - PubMed
Schneiderman 2014
    1. Schneiderman JE, Wilkes DL, Atenafu EG, Nguyen T, Wells GD, Alarie N, et al. Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis. European Respiratory Journal 2014;43(3):817-23. - PubMed
Schünemann 2021
    1. Schünemann HJ, Vist GE, Higgins JP, Santesso N, Deeks JJ, Glasziou P, et al on behalf of the Cochrane GRADEing Methods Group. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.
Selvadurai 2002
    1. Selvadurai HC, Blimkie CJ, Meyers N, Mellis CM, Cooper PJ, Van Asperen PP. Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatric Pulmonology 2002;33(3):194-200. - PubMed
Shoemaker 2008
    1. Shoemaker MJ, Hurt H, Arndt L. The evidence regarding exercise training in the management of cystic fibrosis: a systematic review. Cardiopulmonary Physical Therapy Journal 2008;19(3):75-83. - PMC - PubMed
Skilton 2019
    1. Skilton M, Krishan A, Patel S, Sinha IP, Southern KW. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No: CD009841. [DOI: 10.1002/14651858.CD009841.pub3] - DOI - PMC - PubMed
Stanford 2020
    1. Stanford G, Ryan H, Solis-Moya A. Respiratory muscle training for cystic fibrosis. Cochrane Database of Systematic Reviews 2020, Issue 12. Art. No: CD006112. [DOI: 10.1002/14651858.CD006112.pub5] - DOI - PMC - PubMed
Swisher 2015
    1. Swisher A, Hebestreit H, Mejia-Downs A, Lowman JD, Gruber W, Nippins M, et al. Exercise and habitual physical activity for people with cystic fibrosis: expert consensus, evidence-based guide for advising patients. Cardiopulmonary Physical Therapy Journal 2015 ;26:85-98.
Tannock 1996
    1. Tannock IF. False-positive results in clinical trials: multiple significance tests and the problem of unreported comparisons. Journal of the National Cancer Institute 1996;88(3-4):206-7. - PubMed
Urquhart 2012
    1. Urquhart D, Sell Z, Dhouieb E, Bell G, Oliver S, Black R, et al. Effects of a supervised, outpatient exercise and physiotherapy programme in children with cystic fibrosis. Pediatric Pulmonology 2012;47(12):1235-41. - PubMed
Volkova 2020
    1. Volkova N, Moy K, Evans J, Campbell D, Tian S, Simard C. Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries. Journal of Cystic Fibrosis 2020;19(1):68-79. - PubMed
Ward 2019
    1. Ward N, Stiller K, Holland AE, Australian Cystic Fibrosis Exercise Survey Group. Exercise is commonly used as a substitute for traditional airway clearance techniques by adults with cystic fibrosis in Australia: a survey. Journal of Physiotherapy 2019;65(1):43-50. - PubMed
Ward 2020
    1. Ward N, Morrow S, Stiller K, Holland AE. Exercise as a substitute for traditional airway clearance in cystic fibrosis: a systematic review. Thorax 2020 Dec 22 [Epub ahead of print]. [DOI: 10.1136/thoraxjnl-2020-215836] - DOI - PubMed
Ware 1992
    1. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473-83. [PMID: ] - PubMed
Warnock 2015
    1. Warnock L, Gates A. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database of Systematic Reviews 2015, Issue 12. Art. No: CD001401. [DOI: 10.1002/14651858.CD001401.pub3] - DOI - PMC - PubMed
Wheatley 2011
    1. Wheatley CM, Wilkins BW, Snyder EM. Exercise is medicine in cystic fibrosis. Exercise and Sports Sciences Reviews 2011;39(3):155-60. - PubMed
Wiklund 1990
    1. Wiklund I. The Nottingham Health Profile--a measure of health-related quality of life. Scandinavian Journal of Primary Health Care Suppl 1990;1:15-8. [PMID: ] - PubMed
Williams 2008
    1. Williams DM, Dunsiger S, Ciccolo JT, Lewis BA, Albrecht AE, Marcus BH. Acute affective response to a moderate-intensity exercise stimulus predicts physical activity participation 6 and 12 months later. Psycholgy of Sport and Exercise 2008;9(3):231-45. - PMC - PubMed
Williams 2013
    1. Williams CA, Stevens D. Physical activity and exercise training in young people with cystic fibrosis: current recommendations and evidence. Journal of Sport and Health Science 2013;2(1):39-46.
Wilson 2019
    1. Wilson LM, Morrison L, Robinson KA. Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No: CD011231. [DOI: 10.1002/14651858.CD011231.pub2] - DOI - PMC - PubMed

References to other published versions of this review

Patterson 2019
    1. Patterson KD, Walsh A, McCormack P, Southern KW. Exercise versus airway clearance techniques for people with cystic fibrosis. Cochrane Database of Systematic Reviews 2019, Issue 3. Art. No: CD013285. [DOI: 10.1002/14651858.CD013285] - DOI - PMC - PubMed

Publication types

Substances